Document is current
Any future updates will be listed below
-
Authors
Wang, Binbin https://orcid.org/0000-0003-2885-6428
Saddawi-Konefka, Robert https://orcid.org/0000-0002-9936-1695
Clubb, Lauren M.
Tang, Shiqi
Wu, Di
Mukherjee, Sumit https://orcid.org/0000-0001-9807-7994
Sahni, Sahil https://orcid.org/0009-0006-4678-3903
Dhruba, Saugato Rahman https://orcid.org/0000-0001-5947-6757
Yang, Xinping
Patiyal, Sumeet
Day, Chi-Ping https://orcid.org/0000-0001-5200-2372
Desai, Parth A.
Allen, Clint https://orcid.org/0000-0001-6586-5804
Wang, Kun https://orcid.org/0000-0001-8923-8557
Gutkind, J. Silvio
Ruppin, Eytan https://orcid.org/0000-0002-7862-3940
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 18 August 2025
First Online: 1 September 2025
Competing interests
: E.R. is a co-founder of Medaware Ltd. (), Metabomed (), and Pangea Biomed (). He has divested and serves as an unpaid scientific consultant to the latter company. J.S.G. is a consultant/advisory board member for Pangea Biomed, Radionetics, and io9, and founder of Kadima Pharmaceuticals. The rest of the authors declare no conflicts of interest.
